UBSBF Stock UPDATES Unique Broadband Sys (UBSBF) 0.0112 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Unique Broadband Sys (UBSBF) 0.0112 $UBSBF

Unique Broadband Systems, Inc. Reports Third Quarter 2014 Results
Marketwire - Mon Jul 28, 4:15PM CDT
Unique Broadband Systems, Inc. ("UBS" (TSX VENTURE: UBS.H) today reported its operating and financial results for the third quarter of fiscal 2014, ended May 31, 2014.

IIROC Trading Resumption - UBS.H
CNW Group - Fri Jul 11, 7:07AM CDT
Trading resumes in:

Ontario Court of Appeal Rules in Favour of Unique Broadband Systems, Inc.
Marketwire - Thu Jul 10, 3:24PM CDT
In its previous press releases dated May 6, 2014, November 4, 2013 and May 22, 2013, Unique Broadband Systems, Inc. ("UBS" or the "Company" (TSX VENTURE: UBS.H) announced that (i) certain, but not all, of the claims of Jolian Investments Limited ("Jolian" and Mr. Gerald McGoey, in the aggregate approximate amount of $9.5 million, were disallowed in connection with the Company's ongoing CCAA proceedings, (ii) UBS was granted leave to appeal the judgment of the Honourable Madam Justice Mesbur in which she found that, pursuant to its services agreement with UBS (the "Jolian MSA" , Jolian was entitled to an enhanced severance as a result of the termination of its contract with UBS, which Jolian calculated to be an amount in excess of $4 million, and (iii) the Jolian parties brought a cross-appeal in respect of Justice Mesbur's decision disallowing their claim for payment of the cancellation of the Company's share appreciation rights plan and deferred bonus, and indemnification of legal fees and expenses.

IIROC Trade Halt - Unique Broadband Systems, Inc.
Newsfile Corp - Thu Jul 10, 7:19AM CDT
The following issues have been halted by IIROC:

IIROC Trading Halt - UBS.H
CNW Group - Thu Jul 10, 7:19AM CDT
The following issues have been halted by IIROC:

Unique Broadband Systems, Inc. Announces Transfer to NEX
Marketwire - Fri Jun 27, 7:27AM CDT
Unique Broadband Systems, Inc. ("UBS" or the "Company" (TSX VENTURE: UBS.H) today announces the transfer of its listing from the TSX Venture Exchange (the "TSXV" to the NEX board of the TSXV (the "NEX" as a result of UBS no longer carrying on an active business. The common shares of UBS will commence trading on the NEX effective June 27, 2014 under the symbol UBS.H.

Unique Broadband Systems posts profit in Q1 fiscal 2014
M2 - Mon Jan 27, 3:58AM CST
Unique Broadband Systems Inc (UBS) (TSX.V: UBS) on Friday reported income and comprehensive income of USD43, or USD0.00 per share, for the first quarter of fiscal 2014, ended 30 November 2013.

Unique Broadband Systems, Inc. Reports First Quarter 2014 Results
Marketwire - Fri Jan 24, 4:16PM CST
Unique Broadband Systems, Inc. ("UBS" (TSX VENTURE: UBS) today reported its operating and financial results for the first quarter of fiscal 2014, ended November 30, 2013.

Chief Financial Officer Resigns
Marketwire - Wed Jul 10, 2:52PM CDT
Unique Broadband Systems, Inc. ("UBS" or the "Company" (TSX VENTURE: UBS) announced today that it has received and accepted the resignation of its Chief Financial Officer, C. Fraser Elliott. Mr. Elliott will continue as the Chief Financial Officer of ONEnergy Inc., formerly Look Communications Inc. The board of UBS wishes Mr. Elliott every success in his role at this new enterprise.

MDM, UBS, ERJ, CVBF, ROCM, DIG Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Fri Jun 14, 6:06AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MOUNTAIN PROVINCE DIAMONDS (AMEX:MDM), Unique Broadband Systems Inc (NYSE:UBS), Embraer SA (NYSE:ERJ), CVB FINANCIAL CORPORATION (NASDAQ:CVBF), ROCHESTER MEDICAL CORPORATION (NASDAQ:ROCM), Proshares Ultra Oil & Gas Etf (NYSE IG) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Reasons for Decision Released in Respect of UBS Disputed Claims
Marketwire - Wed May 22, 6:45AM CDT
Unique Broadband Systems, Inc. ("UBS" or the "Company" (TSX VENTURE: UBS) announced today that the Honourable Madam Justice Mesbur of the Ontario Superior Court of Justice released Reasons for Decision in respect of the appeal by Jolian Investments Limited and Mr. Gerald McGoey (together, the "Jolian Parties" of the denial of their claims against the Company. These claims were initially filed in the Company's Companies' Creditors Arrangement Act ("CCAA" proceedings and were initially rejected by UBS on the basis that the actions of the Jolian Parties constituted, among other things, a breach of fiduciary duty and demonstrated a lack of honesty and lack of good faith.

Unique Broadband Systems, Inc. Reports Second Quarter 2013 Results
Marketwire - Mon Apr 29, 9:01AM CDT
Unique Broadband Systems, Inc. ("UBS" (TSX VENTURE: UBS) today reported its operating and financial results for the second quarter of fiscal 2013, ended February 28, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading